Abstract
NOD-like receptors (NLRs) exert pivotal roles in innate immunity as sensors of exogenous or endogenous cellular danger signals. The NLR protein family has a characteristic domain architecture comprising a central nucleotide binding and oligomerization domain (NOD), an N-terminal effector binding domain and C-terminal leucine-rich repeats (LRRs). Mutations in NLR genes are genetically associated with a number of chronic inflammatory diseases of barrier organs. In this chapter, we focus on the influence of NLR regulation and function in the complex pathophysiology of mucosal homeostasis. The understanding of NLR biology may guide our future understanding of how the interaction between the human genome and the metagenome of transient and resident microbiota precipitates into chronic inflammatory disorders, such as Crohn’s disease or atopy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schreiber S, Rosenstiel P, Albrecht M et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6:376–388.
Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucinc-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411:599–603.
Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411:603–606.
Hampe J, Cuthbert A, Croucher PJ et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001; 357:1925–1928.
Hoffman HM, Mueller JL, Broide DH et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29:301–305.
Kanazawa N, Okafuji I, Kambe N et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: Common genetic etiology with Blau syndrome. Blood 2005; 105:1195–1197.
Feldmann J, Prieur AM, Quartier P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002; 71:198–203.
Aksentijevich I, Nowak M, Mallah M et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002; 46:3340–3348.
Inohara, Chamaillard, McDonald C et al. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74:355–383.
Ogura Y, Inohara N, Benito A et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001; 276:4812–4818.
Inohara N, Koseki T, del Peso L et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 1999; 274:14560–14567.
Inohara N, Koseki T, Lin J et al. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 2000; 275:27823–27831.
Abbott DW, Wilkins A, Asara JM et al. The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 2004; 14:2217–2227.
Azevedo C, Sadanandom A, Kitagawa K et al. The RAR1 interactor SGT1, an essential component of R gene-triggered disease resistance. Science 2002; 295:2073–2076.
Yang CW, González-Lamothe R, Ewan RA et al. The E3 ubiquitin ligase activity of arabidopsis PLANT U-BOX17 and its functional tobacco homolog ACRE276 are required for cell death and defense. Plant Cell 2006; 18:1084–1098.
Takahashi A, Casais C, Ichimura K et al. HSP90 interacts with RAR1 and SGT1 and is essential for RPS2-mediated disease resistance in Arabidopsis. Proc Natl Acad Sci USA 2003; 100:11777–11782.
Hahn JS. Regulation of Nod1 by Hsp90 chaperone complex. FEBS Lett 2005; 579:4513–4519.
Janssens S, Burns K, Tschopp J et al. Regulation of interleukin-1-and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 2002; 12:467–471.
Burns K, Janssens S, Brissoni B et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 2003; 197:263–268.
Janssens S, Burns K, Vercammen E et al. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB-and AP-1-dependent gene expression. FEBS Lett 2003; 548:103–107.
Rosenstiel P, Huse K, Till A et al. A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci USA 2006; 103:3280–3285.
Kikuchi-Yanoshita R, Taketomi Y, Koga K et al. Induction of PYPAF1 during in vitro maturation of mouse mast cells. J Biochem (Tokyo) 2003; 134:699–709.
O’Connor Jr W, Harton JA, Zhu X et al. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/ CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J Immunol 2003; 171:6329–6333.
Dinesh-Kumar SP, Baker BJ. Alternatively spliced N resistance gene transcripts: Their possible role in tobacco mosaic virus resistance. Proc Natl Acad Sci USA 2000; 97:1908–1913.
Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995; 374:183–186.
Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001; 11:725–732.
Chamaillard M, Hashimoto M, Horie Y et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4:702–707.
Girardin SE, Boneca IG, Carneiro LA et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300:1584–1587.
Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: Implications for Crohn’s disease. J Biol Chem 2003; 278(8):5509–5512.
Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278:8869–8872.
Tschopp J, Martinon F, Burns K. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003; 4:95–104.
Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell 2004; 116:205–219.
Albrecht M, Domingues FS, Schreiber S et al. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett 2003; 554:520–528.
Rairdan GJ, Moffett P. Distinct Domains in the ARC region of the potato resistance protein Rx mediate LRR binding and inhibition of activation. Plant Cell 2006.
Tanabe T, Chamaillard M, Ogura Y et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004; 23:1587–1597.
Weichart D, Gobom J, Klopfleisch S et al. Analysis of NOD2-mediated proteome response to muramyl-dipeptide in HEK293 cells. J Biol Chem 2006; 281(4):2380–2389.
Girardin SE, Jéhanno M, Mengin-Lecreuix D et al. Identification of the critical residues involved in peptidoglycan detection by Nod1. J Biol Chem 2005; 280:38648–38656.
Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911–920.
Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis: A pathological and clinical entity. JAMA 1984; 251:73–79.
Binder V. Epidemiology of IBD during the twentieth century: An integrated view. Best Pract Res Clin Gastroenterol 2004; 18:463–479.
Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417–429.
Bonen DK, Ogura Y, Nicolae DL et al. Crohn’s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124:140–146.
Netea MG, Kullberg BJ, de Jong DJ et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: Implications for Crohn’s disease. Eur J Immunol 2004; 34:2052–2059.
van Heel DA, Ghosh S, Butler M et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn’s disease. Lancet 2005; 365:1794–1796.
Maeda S, Hsu LC, Liu H et al. Nod2 mutation in Crohn’s disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307:734–738.
Jabs DA, Houk JL, Bias WB et al. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 1985; 78:801–804.
Miceli-Richard C, Lesage S, Rybojad M et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29:19–20.
Chamaillard M, Philpott D, Girardin SE et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100:3455–3460.
Rosé CD, Doyle TM, McIlvain-Simpson G et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005; 32:373–375.
Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001; 344:30–37.
Kabesch M, Peters W, Carr D et al. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003; 111:813–817.
Weidinger S, Klopp N, Rümmier L et al. Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy 2005; 35:866–872.
Kurzawski G, Suchy J, Kladny J et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004; 64:1604–1606.
Alhopuro P, Ahvenainen T, Mecklin JP et al. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 2004; 64:7245–7247.
Papaconstantinou I, Theodoropoulos G, Gazouli M et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 2005; 114:433–435.
Huzarski T, Lener M, Domagala W et al. The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 2005; 89:91–93.
Lener MR, Oszutowska D, Castaneda J et al. Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 2006; 95(2): 141–145.
Rosenstiel P, Hellmig S, Hampe J et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of H. pylori infection. Cell Microbiol 2006; 8(7):1188–1198.
Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: Balancing life and death—a new approach to cancer therapy. J Clin Invest 2005; 115:2625–2632.
da Silva Correia J, Miranda Y, Austin-Brown N et al. Nod1-dependent control of tumor growth. Proc Natl Acad Sci USA 2006; 103:1840–1845.
Zouali H, Lesage S, Merlin F et al. CARD4/NOD1 is not involved in inflammatory bowel disease. Gut 2003; 52:71–74.
McGovern DP, Hysi P, Ahmad T et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005; 14:1245–1250.
Hysi P, Kabesch M, Moffatt MF et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005; 14:935–941.
Braun-Fahrlander C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: Evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003; 3:325–329.
Gewirtz AT. Intestinal epithelial toll-like receptors: To protect. And serve? Curr Pharm Des 2003; 9:1–5.
Jobin C. Intestinal epithelial cells and innate immunity in the intestine: Is CARD15/Nod2 another player? Gastroenterology 2003; 124:1145–1149.
Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010–7017.
Abreu MT, Taylor KD, Lin YC et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 2002; 123:679–688.
Hornef MW, Frisan T, Vandewalle A et al. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002; 195:559–570.
Hisamatsu T, Suzuki M, Podolsky DK. Interferon-{gamma} Augments CARD4/NOD1 Gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J Biol Chem 2003; 278:32962–32968.
Rosenstiel P, Fantini M, Bräutigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD 15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124:1001–1009.
Croucher PJ, Mascheretti S, Hampe J et al. Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003; 11:6–16.
Akey JM, Zhang G, Zhang K et al. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 2002; 12:1805–1814.
Hisamatsu T, Suzuki M, Reinecker HC et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003; 124:993–1000.
Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD 15) mutations in Crohn’s disease are associated with diminished mucosal {alpha}-defensin expression. Gut 2004; 53:1658–1664.
Weichart D, Gobom J, Klopfleisch S et al. Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells. J Biol Chem 2006; 281:2380–2389.
Shin C, Manley JL. Cell signalling and the control of pre-mRNA splicing. Nat Rev Mol Cell Biol 2004; 5:727–738.
Dinesh-Kumar SP, Tham WH, Baker BJ. Structure-function analysis of the tobacco mosaic virus resistance gene N. Proc Natl Acad Sci USA 2000; 97:14789–14794.
Resch A, Xing Y, Modrek B et al. Assessing the impact of alternative splicing on domain interactions in the human proteome. J Proteome Res 2004; 3:76–83.
Hiller M, Huse K, Szafranaski K et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity. Nat Genet 2004; 36:1255–1257.
Hiller M, Huse K, Szafranski K et al. Phylogenetically widespread alternative splicing at unusual GYNGYN donors. Genome Biol 2006; 7:R65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Rosenstiel, P., Schreiber, S. (2009). NOD-Like Receptors—Pivotal Guardians of the Immunological Integrity of Barrier Organs. In: Kishore, U. (eds) Target Pattern Recognition in Innate Immunity. Advances in Experimental Medicine and Biology, vol 653. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0901-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0901-5_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0900-8
Online ISBN: 978-1-4419-0901-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)